Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ropivacaine transversus abdominis plane infusion for postoperative analgesia after abdominal surgery
ACTRN12608000291381Phase 3Completed
- Sponsor
- Western Health
- Start
- Aug 2008
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label, single-arm trial of ropivacaine in postoperative pain, sponsored by Western Health. Primary endpoint: Patient-controlled analgesia morphine cumulative requirement. Started Aug 2008; status: completed.
02
Drugs
ropivacaine
03
Conditions
postoperative pain
Beyond the preview
Go deeper on ACTRN12608000291381.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12608000291381.